Foal monocyte-derived dendritic cells become activated upon Rhodococcus equi infection

Clinical and Vaccine Immunology

Volumn 16, Issue 2, 2009, Pages 176-183

  Flaminio, M Julia B F ^a   Nydam, Daryl V ^a   Marquis, Hélène ^a   Matychak, Mary Beth ^a   Giguère, Steeve ^b  

^a Department of Molecular Biology and Genetics   (United States)

^b University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; CD86 ANTIGEN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 12P35; INTERLEUKIN 12P40; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; CELL ACTIVATION; DENDRITIC CELL; DISEASE PREDISPOSITION; FOAL; HORSE DISEASE; MONOCYTE DERIVED DENDRITIC CELL; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHODOCOCCUS EQUI; TH1 CELL;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD40; ANTIGENS, CD86; CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HISTOCOMPATIBILITY ANTIGENS CLASS II; HORSES; INTERFERON REGULATORY FACTOR-1; INTERLEUKIN-12; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHODOCOCCUS EQUI;

EID: 59649121315     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00336-08     Document Type: Article

References (64)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245-252.
2. Breathnach, C. C., T. Sturgill-Wright, J. L. Stiltner, A. A. Adams, D. P. Lunn, and D. W. Horohov. 2006. Foals are interferon gamma-deficient at birth. Vet. Immunol. Immunopathol. 112:199-209.
3. Chaffin, M. K., N. D. Cohen, and R. J. Martens. 2003. Evaluation of equine breeding farm management and preventative health practices as risk factors for development of Rhodococcus equi pneumonia in foals. J. Am. Vet. Med. Assoc. 222:476-485.
4. Chaffin, M. K., N. D. Cohen, R. J. Martens, R. F., Edwards, and M. Nevill. 2003. Foal-related risk factors associated with development of Rhodococcus equi pneumonia on farms with endemic infection. J. Am. Vet. Med. Assoc. 223:1791-1799.
5. Coccia, E. M. 2008. IFN regulation and functions in myeloid dendritic cells. Cytokine Growth Factor Rev. 19:21-32.
6. Cohen, N. D., M. S. O'Conor, M. K. Chaffin, and R. J. Martens. 2005. Farm characteristics and management practices associated with development of Rhodococcus equi pneumonia in foals. J. Am. Vet. Med. Assoc. 226:404-413.
7. Crow, M. K. 2006. Modification of accessory molecule signaling. Springer Semin. Immunopathol. 27:409-424.
8. Darrah, P. A., M. K. Hondalus, Q. Chen, H. Ischiropoulos, and D. M. Mosser. 2000. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect. Immun. 68:3587-3593.
9. Darrah, P. A., M. C. G. Monaco, S. Jain, M. K. Hondalus, D. T. Golenbock, and D. M. Mosser. 2004. Innate immune responses to Rhodococcus equi. J. Immunol. 173:1914-1924.
10. Fernandez-Mora, E., M. Polidori, A. Lührmann, U. E. Schaible, and A. Haas. 2005. Maturation of Rhodococcus equi-containing vacuoles is arrested after completion of the early endosome stage. Traffic 6:635-653.
11. Flaminio, M. J. B. F., B. R. Rush, and W. Shuman. 1999. Flow cytometric analysis in healthy foals and foals with Rhodococcus equi pneumonia. J. Vet. Intern. Med. 13:206-212.
12. Flaminio, M. J. B. F., A. S. Borges, D. V. Nydam, D. W. Horohov, R. Hecker, and M. B. Matychak. 2007. The effect of CpG-ODN on antigen presenting cells of the foal. J. Immune Based Ther. Vaccines 1:1-17.
13. Gabriele, L., and K. Ozato. 2007. The role of the interferon regulatory factor (IRF) family in dendritic cell development and function. Cytokine Growth Factor Rev. 18:503-510.
14. Garton, N. J., M. Gilleron, T. Brando, H. H. Dan, S. Giguère, G. Puzo, J. F. Prescott, and I. C. Sutcliffe. 2002. A novel lipoarabinomannan from the equine pathogen Rhodococcus equi. Structure and effect on macrophage cytokine production. J. Biol. Chem. 277:31722-31733.
15. Giacomini, E., E. Iona, L. Ferroni, M. Miettinen, L. Fattorini, G. Orefici, I. Julkunen, and E. M. Coccia. 2001. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166:7033-7041.
16. Giguère, S., and J. F. Prescott. 1997. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet. Microbiol. 56:313-334.
17. Giguère, S., and J. F. Prescott. 1998. Cytokine induction in murine macro-phages infected with virulent and avirulent Rhodococcus equi. Infect. Immun. 66:1848-1854.
18. Giguère, S., M. K. Hondalus, J. A. Yager, P. Darrah, D. M. Mosser, and J. F. Prescott. 1999. Role of the 85-kilobase plasmid and plasmid-encoded virulence-associated protein A in intracellular survival and virulence of Rhodococcus equi. Infect. Immun. 67:3548-3557.
19. Giguère, S., B. N. Wilkie, and J. F. Prescott. 1999. Modulation of cytokine response of pneumonic foals by virulent Rhodococcus equi. Infect. Immun. 67:5041-5047.
20. Goriely, S., M. F. Neurath, and H. Goldman. 2008. How microorganisms tip the balance between interleukin-12 family members. Nat. Rev. Immunol. 8:81-86.
21. Hietala, S. K., and A. A. Ardans. 1987. Neutrophil phagocytic and serum opsonic response of the foal to Corynebacterium equi. Vet. Immunol. Immunopathol. 14:279-294.
22. Hines, M. T., K. M. Paasch, D. C. Alperin, G. H. Palmer, N. C. Westhoff, and S. A. Hines. 2001. Immunity to Rhodococcus equi: antigen-specific recall responses in the lungs of adult horses. Vet. Immunol. Immunopathol. 79:101-114.
23. + T lymphocytes. Clin. Diagn. Lab. Immunol. 10:208-215.
24. Honda, K., and T. Taniguchi. 2006. IRFs: master regulators of signaling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644-658.
25. Hondalus, M. K., M. S. Diamond, L. A. Rosenthal, T. A. Springer, and D. M. Mosser. 1993. The intracellular bacterium Rhodococcus equi requires Mac-1 to bind to mammalian cells. Infect. Immun. 61:2919-2929.
26. Hondalus, M. K., and D. M. Mosser. 1994. Survival and replication of Rhodococcus equi in macrophages. Infect. Immun. 62:4167-4175.
27. Horowitz, M. L., N. D. Cohen, S. Takai, T. Becu, M. K. Chaffin, K. K. Chu, K. G. Magdesian, and R. J. Martens. 2001. Application of Sartwell's model (lognormal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J. Vet. Intern. Med. 15:171-175.
28. Jacks, S., S. Giguère, and J. F. Prescott. 2007. In vivo expression of and cell-mediated immune responses to the plasmid-encoded virulence-associated proteins of Rhodococcus equi in foals. Clin. Vaccine Immunol. 14:369-374.
29. Jacks, S., S. Giguère, P. C. Crawford, and W. L. Castleman. 2007. Experimental infection of neonatal foals with Rhodococcus equi triggers adult-like gamma interferon induction. Clin. Vaccine Immunol. 14:669-677.
30. Jain, S., B. R. Bloom, and M. K. Hondalus. 2003. Deletion of vapA encoding virulence associated protein A attenuates the intracellular actinomycete Rhodococcus equi. Mol. Microbiol. 50:115-128.
31. Jiao, X., R. Lo-Man, P. Guermonprez, L. Fiette, E. Deriaud, S. Burgaud, B. Gicquel, N. Winter, and C. Leclerc. 2002. Dendritic cells are host cells for mycobacteria in vivo that trigger innate and acquired immunity. J. Immunol. 168:1294-1301.
32. Kaisho, T., and T. Tanaka 2008. Turning NF-kB and IRFs on and off in DC. Trends Immunol. 29:329-336.
33. Kanaly, S. T., S. A. Hines, and G. H. Palmer. 1995. Cytokine modulation alters pulmonary clearance of Rhodococcus equi and development of granulomatous pneumonia. Infection 63:3037-3041.
34. + Th1 cell line to nude mice effects clearance of Rhodococcus equi from the lung. Infect. Immun. 64:1126-1132.
35. Kawai, T., and S. Akira. 2006. TLR signaling. Cell Death Differ. 13:816-825.
36. Lohoff, M., and T. W. Mak. 2005. Roles of interferon-regulatory factors in T-helper-cell differentiation. Nat. Rev. Immunol. 5:125-135.
37. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macro-phage function. Annu. Rev. Immunol. 15:323-350.
38. McDyer, J. F., Z. Li, S. John, X. Yu, C. Y. Wu, and J. A. Ragheb. 2002. IL-2 receptor blockade inhibits late, but not early, IFN-γ and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-γ production. J. Immunol. 169:2736-2746.
39. Meijer, W. G., and J. F. Prescott. 2004. Rhodococcus equi. Vet. Res. 35: 383-396.
40. Morton, A. C., A. P. Begg, G. A. Anderson, S. Takai, C. Lämmler, and G. F. Browning. 2001. Epidemiology of Rhodococcus equi strains on thoroughbred horse farms. Appl. Environ. Microbiol. 67:2167-2175.
41. Mosser, D. M., and M. K. Hondalus. 1996. Rhodococcus equi: an emerging opportunistic pathogen. Trends Microbiol. 4:29-33.
42. Oppmann, B., R. Lesley, B. Blom, J. C. Timans, Y. Xu, B. Hunte, F. Vega, N. Yu, J. Wang, K. Singh, F. Zonin, E. Vaisberg, T. Churakova, M. Liu, D. Gorman, J. Wagner, S. Zurawski, Y. Liu, J. S. Abrams, K. W. Moore, D. Rennick, R. de Waal-Malefyt, C. Hannum, J. F. Bazan, and R. A. Kastelein. 2000. Novel p19 protein engages IL12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13:715-725.
43. Ozato, K., H. Tsujimura, and T. Tamura. 2002. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Bio-Techniques October(Suppl.):66-68, 70, 72 passim.
44. Patton, K. M., T. C. McGuire, M. T. Hines, R. H. Mealey, and S. A. Hines. 2005. Rhodococcus equi-specific cytotoxic T lymphocytes in immune horses and development in asymptomatic foals. Infect. Immun. 73:2083-2093.
45. Paulnock, D. M., K. P. Demick, and S. P. Coller. 2000. Analysis ofinterferon-gamma-dependent and -independent pathways of macrophage activation. J. Leukoc. Biol. 67:677-682.
46. Polidori, M., and A. Haas. 2006. VapI, a new member of the Rhodococcus equi Vap family. Antonie van Leeuwenhoek 90:299-304.
47. Puech, V., M. Chami, A. Lemassu, M. A. Lanéelle, B. Schiffler, P. Gounon, N. Bayan, R. Benz, and M. Daffé. 2001. Structure of the cell envelope of corynebacteria: importance of the non-covalently bound lipids in the formation of the cell wall permeability barrier and fracture plane. Microbiology 147:1365-1382.
48. Raabe, M. R., C. J. Issel, and R. C. Montelaro. 1998. Equine monocyte-derived macrophage cultures and their applications for infectivity and neutralization studies of equine infectious anemia virus. J. Virol. Methods 71: 87-104.
49. Rosner, B. A. 1986. Nonparametric methods, p. 278-293. In B. Rosner (ed.), Fundamentals of biostatistics, 4th edition. Duxbury Press (ITP), Belmont, CA.
50. Sari, M. A., C. Moali, J. L. Boucher, M. Jaouen, and D. Mansuy. 1998. Detection of a nitric oxide synthase possibly involved in the regulation of the Rhodococcus sp. R312 nitrile hydratase. Biochem. Biophys. Res. Commun. 250:364-368.
51. Schuurhuis, D. H., N. Fu, F. Ossendorp, and C. J. Melief. 2006. Ins and outs of dendritic cells. Int. Arch. Allergy Immunol. 140:53-72.
52. Sekizaki, T., S. Takai, Y. Egawa, T. Ikeda, H. Ito, and S. Tsubaki. 1995. Sequence of the Rhodococcus equi gene encoding the virulence-associated 15-17-kDa antigens. Gene 155:135-136.
53. Tailleux, L., O. Neyrolles, S. Honore-Bouakline, E. Perret, F. Sanchez, J. P. Abastado, P. H. Lagrange, J. C. Gluckman, M. Rosenzwaig, and J. L. Herrmann. 2003. Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells. J. Immunol. 170:1939-1948.
54. Tailor, P., T. Tamura, and K. Ozato. 2006. IRF family proteins and type I interferon induction in dendritic cells. Cell Res. 16:134-140.
55. Takai, S., S. A. Hines, T. Sekizaki, V. M. Nicholson, D. A. Alperin, M. Osaki, D. Takamatsu, M. Nakamura, K. Suzuki, N. Ogino, T. Kakuda, H. Dan, and J. F. Prescott. 2000. DNA sequence and comparison of virulence plasmids from Rhodococcus equi ATCC 33701 and 103. Infect. Immun. 68:6840-6847.
56. Tamura, T., H. Yanai, D. Savitsky, and T. Taniguchi. 2008. The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26:535-584.
57. Tan, C., J. F. Prescott, M. C. Patterson, and V. M. Nicholson. 1995. Molecular characterization of a lipid-modified virulence-associated protein of Rhodococcus equi and its potential in protective immunity. Can. J. Vet. Res. 59:51-59.
58. Tascon, R. E., C. S. Soares, S. Ragno, E. Stavropoulos, E. M. Hirst, and M. J. Colston. 2000. Mycobacterium tuberculosis-activated dendritic cells induce protective immunity in mice. Immunology 99:473-480.
59. Toyooka, K., S. Takai, and T. Kirikae. 2005. Rhodococcus equi can survive a phagolysosomal environment in macrophages by suppressing acidification of the phagolysosome. J. Med. Microbiol. 54:1007-1015.
60. Traub-Dargatz, J. L., M. D. Salman, and J. L. Voss. 1991. Medical problems of adult horses, as ranked by equine practitioners. J. Am. Vet. Med. Assoc. 198:1745-1747.
61. Trinchieri, G., S. Pflanz, and R. A. Kastelein. 2003. The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 19:641-644.
62. Uhl, E. W., S. Giguère, T. J. Jack, and T. Hodge. 2002. Increased pulmonary activation of nuclear factor-κB (NF-κB) in foals inoculated with Rhodococcus equi is associated with increased expression of inflammatory cytokines. Vet. Pathol. 39:132-136.
63. H1 differentiation. Nat. Immunol. 9:9-10.
64. Zink, M. C., J. A. Yager, J. F. Prescott, and M. A. Fernando. 1987. Electron microscopic investigation of intracellular events after ingestion of Rhodococcus equi by foal alveolar macrophages. Vet. Microbiol. 14:295-305.